Pfizer: all 4,072 studies
Page 25 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZCompletedNCT03762928Phase 1
- Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective MeasurementsCompletedNCT03760042Phase 1
- A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy ParticipantsCompletedNCT03758339Phase 1
- Palatability (Taste) of Oral Formulations of BosutinibCompletedNCT03747679Phase 1
- Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy ParticipantsCompletedNCT03742336Phase 1
- A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To CymbaltaWithdrawnNCT03729284Phase 4
- A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of TucatinibCompletedNCT03723395Phase 1
- A Safety Study of Tucatinib in Healthy and Hepatically-Impaired SubjectsCompletedNCT03722823Phase 1
- A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female SubjectsCompletedNCT03662516Phase 1
- Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)CompletedNCT03662191Phase 1
- A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy VolunteersCompletedNCT03656952Phase 1
- A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy VolunteersCompletedNCT03647670Phase 1
- Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of AgeCompletedNCT03642847Phase 1
- Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.CompletedNCT03637790Phase 1
- Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.CompletedNCT03634345Phase 1
- Sedation Of Adult Patients Undergoing Gastrointestinal Endoscopy: A Network Meta-analysisCompletedNCT03632330
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of GlasdegibCompletedNCT03627754Phase 1
- Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in FranceCompletedNCT03621072Phase 1
- A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy SubjectsCompletedNCT03612557Phase 1
- A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)CompletedNCT03608241Phase 1
- Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult SubjectsCompletedNCT03599063Phase 1
- A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese AdultsCompletedNCT03597217Phase 1
- Glasdegib Renal Impairment StudyCompletedNCT03596567Phase 1
- Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin PharmacokineticsCompletedNCT03593707Phase 1
- A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.WithdrawnNCT03580005Phase 4
- Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.WithdrawnNCT03546400Phase 4
- A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHDWithdrawnNCT03536390Phase 4
- Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult SubjectsCompletedNCT03534648Phase 1
- A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple MyelomaTerminatedNCT03530683Phase 1
- A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961CompletedNCT03492697Phase 1
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive, not recruitingNCT03485209Phase 2
- Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male SubjectsCompletedNCT03448172Phase 1
- Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®CompletedNCT03445637
- Expanded Access Use of Tucatinib for HER2+ Metastatic Breast CancerNo longer availableNCT03424473
- Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT03422822Phase 3
- Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's DiseaseWithdrawnNCT03414788Phase 1
- A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy SubjectsCompletedNCT03398473Phase 1
- A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and MoxifloxacinCompletedNCT03386279Phase 1
- A Safety Study of SGN-CD48A in Patients With Multiple MyelomaTerminatedNCT03379584Phase 1
- Safety and Efficacy of Xalkori ROS1CompletedNCT03375242
- A Study To Evaluate Different Formulations Of PF-06865571 In Healthy SubjectsCompletedNCT03372044Phase 1
- Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United StatesCompletedNCT03353480Phase 1
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy SubjectsCompletedNCT03351751Phase 1
- First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult SubjectsCompletedNCT03309241Phase 1
- Bioavailability and Food Effect Study of Two Formulations of PF-06650833CompletedNCT03308110Phase 1
- Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia BTerminatedNCT03307980Phase 2
- A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the BloodCompletedNCT03280173Phase 1
- A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy VolunteersCompletedNCT03273842Phase 1
- Glasdegib Absolute Bioavailability StudyCompletedNCT03270878Phase 1
- A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the BloodCompletedNCT03266705Phase 1
- A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) InfectionCompletedNCT03258502Phase 2
- Absorption, Metabolism, Excretion and Absolute BioavailabilityCompletedNCT03250039Phase 1
- Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy VolunteersCompletedNCT03236493Phase 1
- Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy VolunteersCompletedNCT03232905Phase 1
- A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult SubjectsCompletedNCT03230383Phase 1
- Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of PalbociclibCompletedNCT03220191Phase 1
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy SubjectsCompletedNCT03217604Phase 1
- Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male VolunteersCompletedNCT03184168Phase 1
- Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 PositiveNo longer availableNCT03178071
- A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy SubjectsCompletedNCT03162900Phase 1
- Single-Dose PK Study of GBT440 in Subjects With Renal ImpairmentCompletedNCT03161015Phase 1
- Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512CompletedNCT03146065Phase 1
- A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.CompletedNCT03137134Phase 1
- A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH FormulationCompletedNCT03130556Phase 1
- Lorlatinib - PF-06463922Approved for marketingNCT03127618
- Inotuzumab Ozogamicin - PF-05208773Approved for marketingNCT03127605
- The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy AdultsCompletedNCT03126721Phase 1
- First in Human Study for PF-06667272CompletedNCT03126149Phase 1
- A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult SubjectsCompletedNCT03121664Phase 1
- Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic ImpairmentCompletedNCT03114540Phase 1
- PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR FormulationsCompletedNCT03112148Phase 1
- Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET TacerCompletedNCT03100136Phase 1
- Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571CompletedNCT03092232Phase 1
- Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic ConditionsTerminatedNCT03051711Phase 1
- Multiple Ascending Dose and DDI StudyCompletedNCT03031119Phase 1
- Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher DiseaseWithdrawnNCT03021941Phase 4
- Safety and Tolerability of PF-06818883 in Healthy SubjectsTerminatedNCT03020784Phase 1
- Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme BorreliosisCompletedNCT03010228Phase 1
- Single Dose of PF-06835919 Escalation Study in Healthy Adult SubjectsCompletedNCT02974374Phase 1
- A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 YearsCompletedNCT02955160Phase 1
- A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple MyelomaTerminatedNCT02954796Phase 1
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia SubjectsWithdrawnNCT02947334Phase 3
- Study for MR Formulation of PF-06650833 in Healthy Adult Japanese SubjectsCompletedNCT02936154Phase 1
- Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast CancerWithdrawnNCT02929576Phase 3
- Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In TaiwanCompletedNCT02924584
- A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.CompletedNCT02923791Phase 1
- Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesTerminatedNCT02890368Phase 1
- An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.CompletedNCT02883114Phase 1
- Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy SubjectsCompletedNCT02871037Phase 1
- A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy SubjectsCompletedNCT02855177Phase 1
- A Safety Study of SGN-CD123A in Patients With Acute Myeloid LeukemiaTerminatedNCT02848248Phase 1
- A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy VolunteersCompletedNCT02838264Phase 1
- A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal CancerWithdrawnNCT02836028Phase 2
- Crizotinib Expanded Access Protocol For ROS1 Positive NSCLCNo longer availableNCT02824094
- Topical Multiple Ascending Dose Study for PF-06423264TerminatedNCT02778477Phase 1
- The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy VolunteersCompletedNCT02767089Phase 1
- A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)CompletedNCT02766647Phase 1
- A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)CompletedNCT02766634Phase 1
- Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859CompletedNCT02766621Phase 1